Next Article in Journal
Effects of Fibrous By-Products on Growth Performance, Ileal Nutrient Digestibility, Intestinal Morphology, and Microbiota Composition in Weaned Piglets
Previous Article in Journal
Genomic and Proteomic Characterization of the Deltamethrin-Degrading Bacterium Paracoccus sp. P-2
Previous Article in Special Issue
Probiotic Alternative to Chlorhexidine in Periodontal Therapy: Evaluation of Clinical and Microbiological Parameters
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Microbiome Profiling of Biofilms Formed on d-PTFE Membranes Used in Guided Bone Regeneration

by
Bojana Mohar Vitezić
1,2,*,
Barbara Franović
3,
Ira Renko
4,
Davor Kuiš
5,6,
Gabrijela Begić
1,
Marko Blašković
7,8,
Dragana Gabrić
9,10,
Marina Nikolić
3,
Tamara Šoić Vranić
3,
Diana Veljanovska
3,11 and
Olga Cvijanović Peloza
3
1
Department of Microbiology and Parasitology, Faculty of Medicine, University of Rijeka, Braće Branchetta 20/1, 51000 Rijeka, Croatia
2
Department of Clinical Microbiology, Clinical Hospital Centre Rijeka, Krešimirova 42, 51000 Rijeka, Croatia
3
Department of Anatomy, Faculty of Medicine, University of Rijeka, Braće Branchetta 20/1, 51000 Rijeka, Croatia
4
Laboratory for Computational Biology and Translational Medicine, Division of Electronics, Ruđer Bošković Institute, 10000 Zagreb, Croatia
5
Department of Periodontology, Faculty of Dental Medicine Rijeka, Univeristy of Rijeka, 51000 Rijeka, Croatia
6
Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia
7
Department of Oral Surgery, Faculty of Dental Medicine Rijeka, University of Rijeka, Krešmirova 40/42, 51000 Rijeka, Croatia
8
Dental Clinic Dr. Blašković, Linićeva 16, 51000 Rijeka, Croatia
9
Department of Oral Surgery, School of Dental Medicine, University of Zagreb, Gundulićeva 5, 10000 Zagreb, Croatia
10
Department of Dental Medicine, Clinical Hospital Centre Zagreb, 10000 Zagreb, Croatia
11
Department of Physiotherapy, Faculty of Health Studies, University of Rijeka, Viktora cara Emina 5, 51000 Rijeka, Croatia
*
Author to whom correspondence should be addressed.
Microorganisms 2025, 13(11), 2478; https://doi.org/10.3390/microorganisms13112478
Submission received: 17 September 2025 / Revised: 27 October 2025 / Accepted: 27 October 2025 / Published: 30 October 2025
(This article belongs to the Special Issue Oral Biofilms, 2nd Edition)

Abstract

In guided bone regeneration (GBR) procedures, d-PTFE membranes are often used as a barrier to promote alveolar ridge regeneration. The aim of this randomized clinical trial was to examine the microbial diversity and structure of biofilms on two types of d-PTFE membranes, Permamem® and Cytoplast™, over four-week oral cavity exposure periods. Bacterial biofilm analysis was performed using 16S rRNA next-generation sequencing (NGS) on 36 samples (20 Permamem® and 16 Cytoplast™). The results showed significant differences in the microbial profiles: Cytoplast™ membranes showed reduced microbial diversity and an enhanced proportion of pathobionts like Selenomonas, Segatella, Fusobacterium and Parvimonas, which are associated with periodontal and peri-implant diseases and alveolar bone loss. Permamem® membranes promoted colonization by bacteria associated with healthy oral conditions, such as the genera Streptococcus, Kingella and Corynebacterium. Overall, our results showed that Cytoplast™ membranes generate a specific type of biofilm, leading to reduction in health-related bacterial species and facilitating growth conditions for dysbiosis shift. Further research and patient follow-ups are essential to thoroughly evaluate the clinical implications of different d-PTFE membranes used in guided bone regeneration.

1. Introduction

The oral cavity contains a complex and diverse microbial ecosystem comprising over 700 bacterial species that exist in a state of dynamic equilibrium. In oral health, this microbiome is predominantly colonized by aerobic and facultative anaerobic bacteria, such as various species of Streptococcus spp., Actinomyces spp., Rothia spp., Fusobacterium spp., Neisseria spp., Haemophilus spp. and Leptotrichia spp. Specific sites are colonized with different proportions of microaerophilic and anaerobic bacteria like Peptostreptococcus spp., Veillonella spp., Segatella spp., Campylobacter spp., Lactobacillus spp., Bifidobacterium spp., Corynebacterium spp., Propionibacterium spp., Desulfobacter spp., Selenomonas spp. and Treponema spp. [1]. These commensal microorganisms play a key role in maintaining oral homeostasis through competitive restriction of pathogens, modulation of the immune system and formation of protective biofilms. Disruption of oral microbiome homeostasis and development of dysbiosis may cause various diseases and also impair tissue and bone regeneration. Microbial succession proceeds in clearly defined phases from initial colonization by aerobic Gram-positive bacteria, through a transitional phase with anaerobic opportunists, to a late phase dominated by anaerobic pathogens associated with periodontal and peri-implant diseases and impaired healing [2]. The microbial dynamics during this period may significantly affect the outcome of regeneration, including implant integration and volumetric bone restoration.
Guided bone regeneration (GBR) is a standardized method in dental medicine that enables the preservation and restoration of the alveolar ridge, especially in preparation for implant placement. A key component of this method is the use of barrier membranes that physically prevent the migration of fibroblast and epithelial cells into the regeneration area, allowing osteoprogenitor cells to grow without interference [3]. Dense polytetrafluoroethylene (d-PTFE) membranes, such as Cytoplast™ and Permamem®, are increasingly used due to their low porosity, resistance to bacterial penetration and suitability for clinical application without primary wound closure [4,5]. These membranes allow predictable regeneration, even in cases where they are exposed to the oral cavity, with minimal risk of infection and graft failure [6].
Despite these advantages, the formation of dental biofilm on the surface of d-PTFE membranes, where they provide specific niche for bacterial colonization, remains a clinical challenge. In clinical settings, premature or excessive colonization of the membrane surface by pathogenic microorganisms may lead to disrupted regeneration, including membrane exposure, inflammation or graft failure [7]. Bacterial adhesion depends on the microstructural characteristics of the membrane, including its degree of crystallinity, nanoscale roughness and topological artifacts. The lower nanoroughness of the Cytoplast™ membrane results from its higher crystallinity (78.6%), which results in stronger bacterial adhesion compared to the lower crystallinity (34.2%) of the Permamem® membrane [8,9]. A recent randomized clinical trial found that membranes with a rougher inner surface, such as Cytoplast™, exhibit higher bacterial adhesion (visualized with electron microscopy) of the microbiome compared to Permamem® membranes [8,9]. Specific niches created around specific membrane types represent major researching and therapeutic challenges.
Peri-implantitis is a biofilm-mediated inflammatory disease that affects the tissues around dental implants—peri-implant mucosa and alveolar bone. If left untreated, it causes gradual bone loss and may lead to implant failure. The peri-implant niche supports a diverse microbial population, with anaerobic Gram-negative bacteria playing an important role. Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola and Fusobacterium nucleatum are important periopathogens that release virulence factors that cause tissue damage and regulate host immunological responses [10]. Furthermore, Gram-positive organisms such as Staphylococcus epidermidis and enteric bacteria have been found in higher abundance in peri-implantitis locations than in healthy implants, indicating a diverse microbial dysbiosis driving disease progression. The analytical advantages of next-generation sequencing highlight the crucial role which biofilm architecture and interspecies interactions have in the pathophysiology of peri-implantitis, by enabling thorough profiling of microbial changes from peri-implant health to peri-implant diseases. Comprehending these microbiological boundaries is crucial for precise diagnosis as well as the creation of focused treatment methods, such as host-modulation techniques, photodynamic therapy and mechanical debridement with adjunct antimicrobials [11].
The formation and colonization of biofilms on different surfaces like dental implants, d-PTFE membranes and others involves a different process compared to natural teeth. When saliva comes into contact with the implant surface, salivary proteins immediately adhere and form an acquired pellicle. This pellicle differs from the enamel pellicle containing α-amylase, mucins, proline-rich proteins and secretory IgA, while lacking low-molecular weight mucins and cystatins. Bacterial colonization begins in areas protected from shear forces, driven by electrostatic, Van der Waals and hydrophobic interactions that place bacteria close to the pellicle-coated surface. Initial adhesion becomes irreversible once bacteria bind to the pellicle proteins. Early biofilm development is dominated by facultative Gram-positive cocci, rods and bacilli, with limited Gram-negative anaerobes. Streptococcus sanguinis and Actinomyces naeslundii are the primary colonizers, and Streptococcus spp. rapidly establish themselves on exposed implant surfaces. Titanium surfaces create a unique microenvironment that alters ecological succession—early peri-implant biofilms show reduced levels of A. naeslundii and marked co-aggregation with Veillonella spp. As early colonizers multiply, they change the environment and facilitate the adhesion of secondary colonizers through co-aggregation. After days of maturation, a microbial change occurs: the number of Gram-negative cocci, spirochetes and motile bacilli increases, especially in the submucosal areas. This change—combined with immune dysfunction—can cause peri-implant mucositis, a precursor to peri-implantitis [12].
Gram-positive cocci and non-motile bacilli predominate in the healthy peri-implant microbiome, while anaerobic Gram-negative organisms are detected in minor portions. Commensal microorganisms like Segatella multiformis, Kingella oralis, Actinomyces massiliensis and Lautropia mirabilis help maintain community homeostasis by restricting adhesion of possible pathogens in the supramucosal niche. In addition to Actinomyces naeslundii, A. oris, A. meyeri and A. massiliensis, the submucosal sulcus is home to a more complex consortium that includes Streptococcus sanguinis, S. salivarius and S. oralis, Veillonella dispar, Rothia aeria, Rothia dentocariosa, Capnocytophaga sputigena, Haemophilus parainfluenzae, Corynebacterium matruchotii, Leptotrichia sp., Neisseria sp., Mycoplasma salivarium, Eikenella corrodens and non-pathogenic Fusobacterium sp. Low concentrations of the traditional periodontal pathogens Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Fusobacterium nucleatum, Tannerella forsythia, Treponema denticola, Segatella intermedia, Parvimonas micra and Streptococcus intermedius remain in healthy peri-implant sulci without endangering implant stability in well-maintained individuals, even in the absence of clinical inflammation [12]. Members of the Actinomycetia class, bacilli like Granulicatella, Gammaproteobacteria (like Vibrio), Epsilonproteobacteria (like Campylobacter) and genera found only in health, like Filifactor, Bradyrhizobium, Dialister, Paludibacter, Staphylococcus, Acinetobacter and Propionibacterium are among the health-associated taxa enriched at these sites. A core network composed of Firmicutes, Spirochaetes and Bacteroidetes underlies both supramucosal and submucosal communities. The preservation of peri-implant health is determined by the balance of site-specific microbial interactions [13].

1.1. Peri-Implant Mucositis Microbiome

Increased cocci, motile bacilli and spirochetes are indicators of peri-implant mucositis, an intermediate microbiological condition between peri-implantitis and health. Mucositis sites contain elevated levels of periodontal pathogens, including Segatella intermedia, P. gingivalis, T. forsythia, T. denticola and Segatella denticola. Recent taxonomic research (2023) has subdivided the genus Prevotella into seven genera, introducing four new genera named Segatella, Hoylesella, Leyella and Palleniella [14]. After implant placement, patients with a history of periodontitis exhibit submucosal biofilms that mirror their initial periodontal flora and are enriched in enteric rods like Fusobacterium spp., P. gingivalis, T. forsythia, Campylobacter rectus, Dialister pneumosintes and Peptostreptococcus micros, according to case studies. According to recent research, the genera Segatella and Fusobacterium may be biomarkers of mucositis, indicating a tendency in people who have previously had periodontal disease [13].

1.2. Peri-Implantitis Microbiome

Deepened pockets and anaerobic environments that support intricate bacterial, fungal and viral biofilms lead to peri-implantitis. Gram-negative anaerobes as A. actinomycetemcomitans, Capnocytophaga spp., F. nucleatum, S. intermedia, T. forsythia, T. denticola, T. maltophilum and P. gingivalis dominated the submucosal flora, which was initially compared to periodontitis. More opportunists, such as Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa, Peptostreptococcus species, Neisseria species, Porphyromonas endodontalis, Lactococcus lactis, Filifactor alocis, Escherichia coli, Enterobacter species, Helicobacter pylori and Candida sp., are discovered by sophisticated molecular techniques. One-third of locations have Epstein–Barr virus and human cytomegalovirus co-infections, which may reduce local immunity and promote pathogenic development [14].
Considering mentioned different microbiome biofilm architectures, the concept of personalized regenerative therapy based on the patient’s microbiological profile is gaining interest. Microbiome analysis prior to or during therapy may potentially guide the selection of the optimal membrane material or the implementation of additional antimicrobial strategies [15,16].
Elucidating these microbial dynamics may also contribute to the development of evidence-based protocols for membrane selection and timing of surgical interventions, ultimately improving patient outcomes in regenerative dentistry.
The aim of this study was to analyze microbial diversity and structural composition of mature biofilm on two different d-PTFE membranes during a four-week period following guided bone regeneration. Bacterial biofilm was analyzed using 16s rRNA next-generation sequencing (NGS) in order to identify microbial dynamics and its dysbiosis potential.

2. Materials and Methods

2.1. Study Design and Patient Selection

This study included patients who required at least one tooth extraction and subsequent implant placement. Of the 56 patients initially evaluated, 39 met the inclusion criteria and were randomly assigned to one of two study groups. Detailed protocol, inclusion/exclusion criteria, sample size and other study factors were described in the article by Franović et al. [8]. Individuals were assigned to intervention groups based on the web-based randomization process. By the end of our study, we managed to collect and analyze 36 d-PTFE, 20 Permamem® and 16 Cytoplast™ membranes from patients after a four-week healing period, following guided bone regeneration. In our study, 39 membranes, from 39 patients, were extracted. Membranes extracted from 3 excluded patients had insufficient (below the detection limit) DNA isolate concentrations and were consequently eliminated from NGS analysis. These exclusions were distributed across the two membrane types and were not disproportionately associated with either Permamem® or Cytoplast™ membranes, minimizing the risk of systematic bias associated with membrane type.
The study comprised men and women over the age of 18 who were in good general health and had tooth extraction grounds due to vertical or horizontal fractures extending 2 mm or more apically from the gingival border, failed endodontic or other conventional therapies. Exclusion criteria were as follows: patients with head and neck irradiation, those undergoing intravenous or oral bisphosphonate therapy, patients with untreated periodontal disease or uncontrolled diabetes, patients on immunosuppressive or long-term corticosteroid therapy, pregnant and lactating women and patients who smoked more than 10 cigarettes per day.

2.2. Grafting Surgery

Before surgery, all subjects had their plaque and calculus removed mechanically and were instructed on proper oral hygiene. An oral antibiotic (Klavocin® bid 1000 mg, Pliva, Zagreb, Croatia) was given an hour before surgery. Additionally, patients rinsed with a 0.2% chlorhexidine digluconate solution (Parodontax® 0.2%, Brentford, London, UK) prior to surgery.
A socket grafting operation was conducted immediately after tooth extraction in both groups using a composite bone graft including 50% autogenous bone and 50% bovine xenograft (Cerabone®, Botiss Biomaterials GmbH, Zossen, Germany). Following graft placement, the grafted site was coated with one of two membranes based on their pre-assigned group as follows:
Group P: The grafted site was coated with a d-PTFE membrane (Permamem®, Botiss Biomaterials GmbH, Zossen, Germany).
Group C: The grafted site was coated with an alternate d-PTFE membrane (Cytoplast™, Osteogenics Biomedical, Lubbock, TX, USA).
Four weeks after extraction and grafting, the d-PTFE membrane was removed in both groups, leaving the pseudoperiosteum covering the crestal section of the extraction socket exposed to promote healing. After six months of healing, implants were placed in the prepared spot. Detailed protocol was described in the article by Franović et al. [8].

2.3. Ethical Considerations

This RCT followed the guidelines outlined in the Declaration of Helsinki. The Ethics Committee of the Faculty of Medicine at the University of Rijeka (class: 003-05/20-1/151, number. 2170/29-02/1-20-2) accepted the study of human volunteers who gave informed consent. This study followed ethical guidelines and was accepted as an RCT, which is registered on ClinicalTrials.gov (NCT06694844). This study followed the CONSORT standards for reporting randomized controlled trials. All participants provided informed permission and voluntarily agreed to participate after being fully briefed on the study’s methods and requirements.

2.4. Sonication and DNA Extraction

Following membrane extraction, the d-PTFE membranes were placed in Transystem Amies w/o Ch (Copan) and promptly transferred to the Faculty of Medicine Rijeka for further examination. Upon arrival, the membranes were rinsed 3× and placed into 2.5 mL saline and transferred to an ultrasonic bath (BANDELIN electronic GmbH & Co. KG, Berlin, Germany) under standardized conditions of 3 min/40 kHz to release d-PTFE membrane biofilm into the sonicate. Approximately 1 mL of the resulting sonicate was collected and frozen at −80 °C (Heraeus Group, Hanau, Germany) for subsequent DNA extraction and next-generation sequencing. Extractions of DNA were performed on an automated nucleic acid extraction system SACACE—SaMag-12 (Sacace Biotechnologies, Como, Italy) with SaMag Bacterial DNA Extraction kit -SM006 (Sacace Biotechnologies, Como, Italy). Prior to DNA extraction, sonicates were centrifugated for 10 min at 15,000 rpm and the supernatant was removed with 200 µL of sediment left at the bottom of the tube. Afterward, 200 µL of lysis buffer (20 mM Tris/HCL, 2 mM EDTA, 1% Triton X-100, pH 8) was added to sediment with 50 µL of freshly prepared lysozime (0.02 g lysozime in 500 µL 20 mM TrisHCl). The mixture was incubated in a thermomixer for 45 min at 37 °C and 900 rpm. After 45 min of incubation, 50 µL of proteinase K was added and further incubated for 30 min at 56 °C and 900 rpm. Following described pretreatment of sonicates, the entire volume of liquid was transferred into sample tubes at SaMag-12 instrument (Sacace Biotechnologies, Como, Italy) and extraction was performed automatically according to SaMag Bacterial DNA Extraction kit protocol with settings for sample volume 400 µL and elution volume 50 µL. After DNA extraction, concentrations of DNA were determined with Qubit fluorometer (TermoFisher Scientific, Waltham, MA, USA) with the Qubit DNAHS kit (TermoFisher Scientific, Waltham, MA, USA) according to the manufacturer’s protocol.

2.5. 16S rRNA Amplification and Next-Generation Sequencing Analysis

Microbial diversity and abundance in supragingival dental biofilms of the examined groups were assessed by sequencing of bacterial 16s rRNA gene using next-generation sequencing (NGS) on the Illumina platform. Thirty-six DNA isolate samples from membrane sonicates (20 membrane samples from the Permamem® group and 16 membrane samples from the Cytoplast™ group) were sent to the Molecular Research Laboratory (MRDNA) in Texas, USA, where amplicon sequencing was performed using a set of 341F (5′-CCTAYGGGRBGCASCAG-3′) and 806R (5′-GGACTACNNGGGTATCTAAT-3′) primers. The resulting sequencing data were obtained from “Illumina’s BaseSpace Sequence Hub” as paired-end, demultiplexed fastq files. Data processing was carried out using the software package Quantitative Insights Into Microbial Ecology 2 (QIIME2) (2024.2) [17]. The workflow included filtering and denoising using the DADA2 (2024.2) program (integrated within QIIME2), concatenation of the sequences and control for the presence of possible chimeras [18]. For the taxonomic determination of microorganisms, the Naive Bayes classifier tool in QIIME2 was applied, adapted to work with the SILVA database, version 138 [19]. The diversity and richness of all samples were estimated based on beta diversity (Bray–Curtis dissimilarity) using the seaborn, matplotlib, pandas, and matplotlib libraries and Python programming language, version 3.12, within the Pycharm environment (3.12) [20]. Graphical representations were created using RStatistical Software (v4.4.2; R Core Team 2021) using ggplot2 package (3.5.2) and MicrobiomeAnalyst 2.0 web-based platform [21].

2.6. Statistical Analysis

Data collected during the study were analyzed using conventional descriptive statistical methods. The normality of data distribution was assessed using QQ plots. Most analyses were performed using the Python programming language (version 3.12), within the PyCharm environment, utilizing the pandas, seaborn, and matplotlib libraries [20,22]. Additional statistical analyses were conducted using the R programming language (version 4.4.2), specifically the ALDEx2, bioconductor package (analysis of differential abundance taking sample and scale variation into account (1.38) [23]. This method relies on Monte Carlo sampling from the Dirichlet distribution and enables robust estimation of differential taxon abundance in next-generation sequencing (NGS) data, with automatic application of Benjamini–Hochberg (BH) correction. Results were considered statistically significant when the we.eBH-Wilcoxon p-value (Benjamini–Hochberg corrected) was below 0.05.

3. Results

To assess the diversity and differences in the biofilm microbiome profile between d-PTFE Cytoplast™ and Permamem® membrane-sonicated DNA samples, NGS results were comparatively analyzed.
Permamem® membrane group included 20 samples marked as M2-M9, M11-M15, M17, M23-M27 and M43.
Cytoplast™ membrane group included 16 samples marked as M16, M28-M35, M37-M39, M42 and M46-M48.
To determine whether there were significant differences between the groups, the most abundant (presented in the core microbiome) and rarest group-specific and disease-specific bacterial genera and species were analyzed. After processing, the total number of reads across all samples was 1,099,274 with an average number of reads for Cytoplast™ samples of 377,862, and for Permamem® samples of 351,592 reads. Taxonomic classification of the sequences identified 284 species linked to a total of 13 phyla across samples. Among them, 275 were related to Permamem® samples and 242 to Cytoplast™ samples.
At the phylum level, clear differences were observed between the two groups (Figure 1).
Of the 13 bacterial phyla detected in both groups, the most dominant in the Permamem® group were Pseudomonadota (40%), Bacillota (30%) and Fusobacteriota (16%), while in Cytoplast™ group, Fusobacteriota was most dominant (46%), followed by Bacillota (25%) and Pseudomonadota (13%). In the Permamem® group, Actinomycetota (7%) and Bacteroidota (6%) were the less abundant phyla, whereas in the Cytoplast™ group, Bacteroidota (10%) and Actinomycetota (6%) showed lower abundance. Other phyla, including Spirochaetota, Mycoplasmatota, Synergistota, Acidobacteriota, Verrucomicrobiota, Gemmatimonadota, Desulfobacterota and Campylobacterota, were observed only at very low relative abundances (<1%) and showed inconsistent presence across groups.
To further explore the differences between the two groups at lower taxonomic levels, a heat tree analysis was performed using the MicrobiomeAnalyst 2.0 web tool [21] (Figure 2). Differences between groups were defined using the Wilcoxon test at three significance thresholds (p < 0.05, p < 0.01, p < 0.001) to strengthen the validity of the findings. In the resulting heat trees, nodes represent species, node size represents abundance, and node color indicates the significance of the difference between groups. Blue stands for enhanced species presence in Cytoplast™ and red stands for enhanced species presence in Permamem® group).
As shown in Figure 2 and Table 1, the number of differing species at a significance threshold of p < 0.05 was 28. Differences remain evident, even at the more stringent p < 0.01 value, with 23 species and at the most stringent cut off p < 0.001, the two groups differ in 15 species.
Of 23 species, which differed between groups, detected at p < 0.01 value, the majority in the Cytoplast™ group belonged to the genera Fusobacterium and Segatella, whereas in the Permamem® group, the dominant species belonged to genera Kingella, Klebsiella and Corynebacterium (Figure 2b,c and Table 2). At the most stringent cut off of p < 0.001, the two groups differ in 15 species belonging to the genera Segatella, Haemophilus, Kingella, Fusobacterium, Corynebacterium, Treponema and Mogibacterium, with all listed taxa except Kingella and Corynebacterium being more abundant in the Cytoplast™ group compared to Permamem®.
To assess the potential presence of false positive results, ALDEx2 analysis (analysis of differential abundance taking into account sampling variation) was performed. During the analysis, the Benjamini–Hochberg correction was applied to control for false positive results. Genera and species with a p-value (Wilcoxon Effect—Benjamini–Hochberg) of less than 0.05 were considered statistically significant. The test results are presented in Table 2a,b.
Based on the results, among the statistically significant bacterial genera, the genus Kingella shows the highest positive difference in abundance between the Permamem® and Cytoplast™ groups, with its presence being significantly more pronounced in the Permamem® group. In contrast, the genera Segatella and Fusobacterium showed a statistically significant increase in the Cytoplast™ group, indicating distinct microbial profiles between the analyzed groups (Table 2a).
A similar trend was observed at the species level, where Kingella bonacorsii was identified as the species with the highest positive difference in abundance in favor of the Permamem® group. On the other hand, species of the genus Fusobacterium exhibit a higher relative abundance in the Cytoplast™ group compared to Permamem®, further supporting the presence of a distinct microbial dominance within that group (Table 2b).
Beta diversity analysis revealed no significant differences between the two groups (p = 0.5).
In order to further explore detected bacteria, the most abundant bacteria of the core microbiome were identified at the genus and species level (Figure 3), as well as for the rare bacteria (Figure 4).
The relative abundances of bacterial taxa at the genus level differed substantially between the Cytoplast™ and Permamem® groups. The Cytoplast™ group was particularly enriched in the genera Fusobacterium (~30%), Leptotrichia (~17%) and Streptococcus (~15%). In contrast, the Permamem® group exhibited a distinct distribution, with Fusobacterium (~8%) and Leptotrichia (~7%) being less represented, while Streptococcus (~21%) emerged as the dominant genus (Figure 3a).
At the species level, the profiles were similarly non-uniform. In the Permamem® group, the most abundant species included Streptococcus mutans (~10.5%), Morococcus cerebrosus (~8.5%) and Streptococcus sanguinis (~6.5%), followed by Aggregatibacter aphrophilus (~4.8%) and Leptotrichia wadei (~3%). The same species were present in the Cytoplast™ group, but at markedly different relative abundances: S. mutans (~5.5%), M. cerebrosus (~4%), S. sanguinis and A. Aphrophilus, with L. wadei detected at low abundance (Figure 3b).
Consistent with Figure 3a, the Cytoplast™ group was dominated by the Fusobacterium species (F. Nucleatum, F. animalis, F. canifelinum, F. vincentii and F. nucleatum), which in Permamem® samples were detected only at <2.5% relative abundance (Figure 3b).
With respect to the less abundant but noteworthy bacterial genera, several taxa were relatively enriched in the Cytoplast™ group, including Campylobacter (0.65%), Dialister (0.22%), Treponema (0.31%), Parvimonas (0.63%) and Tannerella (0.42%). Among these genera, Campylobacter (0.5%) was the most abundant in the Permamem® group, followed by Parvimonas (0.38%) and Dialister (0.21%). Treponema and Tannerella, as well as the majority of genera depicted in Figure 4a, were detected at levels below 0.1% (Figure 4a).
At the species level (Figure 4b), the Permamem® group was characterized by the predominance of Corynebacterium suiscordis (0.041%) and Filifactor alocis (0.05%), which were only marginally detected in the Cytoplast™ group (0.001% and 0.008%, respectively). In contrast, the Cytoplast™ group was dominated by several rarely represented species, including Anaeroglobus geminatus (0.059%), Actinomyces massiliensis (0.042%), Filifactor fastidiosum (0.08%) and Pseudostreptobacillus honkongensis (0.058%).
Furthermore, it was observed that some bacterial genera were uniquely detected in only one of the two groups, as illustrated in Figure 5.
With respect to bacteria specific to each group, the Permamem® samples contained a greater number of uniquely identified genera compared to the Cytoplast™ group (Figure 5). The most striking differences were observed for the genera Francisella, Reyranella and Natronoflexus. Francisella dominated in the Permamem® samples, with a substantial relative abundance of 2.4%, while Reyranella (0.1%), Rhodoplanes and Hungatella (0.04%) were detected at lower levels. In contrast, the Cytoplast™ samples contained members of the genera Natronoflexus (0.7%), Tissierella (0.04%), Johnsonella (0.2%) and Limosilactobacillus, none of which were detected in the Permamem® group. Other genera, not explicitly mentioned here but displayed in Figure 5, belonged to the Permamem® group and were present at very low abundances (<0.1%).
Furthermore, among the detected taxa, particular attention was given to species of relevance in the context of periodontitis, implant and bone loss. Nine bacteria genera that were observed included Dialister, Filifactor, Fretibacterium, Mogibacterium, Parvimonas, Peptostreptococcus, Selenomonas, Shuttleworthia and Solobacterium.
Analysis of their relative abundances revealed that Cytoplast™ samples exhibited consistently higher levels of all selected genera compared to Permamem®, most prominently Selenomonas, exhibiting the strongest enrichment, reaching values above 10% in some samples, while being significantly reduced in Permamem® (2%). Similarly, Parvimonas and Peptostreptococcus displayed consistently higher levels in Cytoplast™samples, with Permamem® showing only minimal representation(Figure 6). Mogibacterium also showed a higher representation in Cytoplast™ (median ~0.05%) but was almost absent in Permamem® samples. Other genera, including Dialister, Fretibacterium, Shuttleworthia and Solobacterium followed a similar trend. This observation was further supported by statistical testing: differences in relative abundances were evaluated using the Wilcoxon rank-sum test with Benjamini–Hochberg (BH) correction for multiple comparisons, which confirmed statistically significant differences for Dialister, Mogibacterium, Parvimonas and Peptostreptococcus.

4. Discussion

The aim of this study was to report a complex microbial composition of mature biofilm on two different d-PTFE membranes exposed to the oral cavity environment for four weeks, following guided bone regeneration in vivo. The composition of bacterial biofilm is niche-specific and location-dependent. 16s rRNA sequencing and novel bioinformatic pipelines enable detailed analysis and insights in composition of microbial colonizers on d-PTFE membranes, which present a specific niche for development of unique microbial communities. All patients in our study received prophylactic antibiotics prior to surgery according to standard clinical protocols to reduce the risk of postoperative infections. We acknowledge that systemic exposure to antibiotics can alter the composition of the oral microbiome and potentially influence subsequent biofilm formation. However, all participants received the same antibiotic regimen under controlled conditions; any effects on the oral microbiome are expected to be relatively uniform across study groups and minimize variability between groups.
The different membrane-type surfaces were, as expected, colonized by a perplexing palette of diverse microorganisms. Bacterial adhesion depends on the different microstructural characteristics of each used Cytoplast™ (C) or Permamem® (P) membrane (degree of crystallinity, nanoscale roughness or topological artifacts). Comparison of overall 16s rRNA sequence read number was conducted and higher values were detected on C membranes, suggesting a higher rate of adhesion and bacterial accumulation compared to P membranes. Results of scanning electron microscopy (SEM) presented in a previously published article (8), showed denser extracellular matrix and bacterial clusters on C membranes compared to P membranes, supporting the finding of higher bacterial adhesion and accumulation on C membranes.
When comparing species diversity, 275 species were detected on P membranes compared to 242 species detected on C membranes; reduced diversity of species in oral microbiota was already detected and described as dysbiosis which represent the shift in balance of a specific niche microbial community [24].
Previously demonstrated significant structural and surface differences between dense PTFE Cytoplast™ and Permamem® membranes [9] suggest that membrane material and topography may influence early microbial selection and could have contributed to the dysbiotic pattern observed in Cytoplast™ biofilms. Dysbiosis may diminish species contributing to the healthy balance in specific biofilms and contribute to the overgrowth of pathobionts and oral pathogens, leading to inflammation, periodontitis, tooth, implant and bone loss.
Beta diversity measures overall community composition differences between groups and our results revealed no significant difference between P and C membrane types. Differential abundance analysis such as ALDEx2 evaluates each taxon individually, identifying specific taxa whose relative abundances differ between groups, even if these changes do not substantially alter the overall community structure like described with beta diversity.
Considering differences between researched membrane types, dominance of Pseudomonadota (40%), Bacillota (30%) and Fusobacteriota (16%) was detected in the P group while in the C group, Fusobacteriota was in majority (46%), followed by Bacillota (25%) and Pseudomonadota (13%). These findings may indicate differing biofilm maturation states between membrane types. Fusobacteriota is consistent with more mature anaerobic biofilms, whereas Pseudomonadota may reflect earlier colonization stages, suggesting slower and delayed biofilm formation on P membranes. Since a single time point was analyzed, this interpretation remains hypothetical. Longitudinal sampling would provide valuable insights into biofilm succession; unfortunately, in our study, we could only have a single endpoint of four weeks, which corresponds to the required clinical timeframe for removal of the d-PTFE membrane after guided bone regeneration. This time point provides insight primarily into the state of the mature biofilm and the composition of its microbial community. Earlier removal of membranes would interrupt the bone healing process and disrupt patient recovery, so it was impossible to perform it in a clinical trial.
The P and C groups also differed among prevalent genera: In the P group, Streptococcus (21%), Haemophilus (10%), Fusobacterium (8%) and Neisseria (7%) were detected. On the other hand, the C group exhibited a high abundance of Fusobacterium (29%) and Streptococcus (15%) but differed in the remaining dominant taxa. Considering detected species, the P group was dominated by Streptococcus mutans (10%), Haemophilus parainfluenzae (10%) and Moraxella cerebrosus (8%) while in the C group, species of the Fusobacterium genus prevailed: F. animalis (6%), F. canifelinum (6%) and F. vincentii (6%). These results suggest slower biofilm formation on P membranes with higher abundance of Streptococcus spp. while a higher Fusobacterium spp. level indicates developed maturity of biofilm and shift to thicker anaerobic conditions on the C membrane, leading to possible dysbiosis [24]. Fusobacterium acts as a “bridge” organism facilitating co-aggregation with late colonizers and accelerates the maturation of pathogenic biofilm [25,26,27,28,29,30,31].
Statistically significant bacterial genera with enhanced presence in the P membrane group were as follows: Kingella, Corynebacterium, Haemophilus and species: Kingella bonacorsii and Hemophilus parainfluenzae indicate an enhanced presence of health-associated genera and species which are crucial for pathogen and pathobiont limitation. In contrast, pathogens including genera Segatella and Fusobacterium with different species presented significantly increased colonization on C membranes compared to P membranes, indicating distinct microbial profiles between the analyzed groups. When analyzing achieved data altogether, one should conclude that the C membrane may generate a microenvironment inside a specific niche, which creates favorable conditions for microbial community shift in dysbiosis direction. Creating such a kind of biofilm on C membranes leads to reduction in health-related bacterial species, creates space and facilitates growth conditions for pathobiont and pathogen species dominance. When analyzing rare bacteria detected on both membrane types, Francisella dominated in the P membrane followed by Reyranella, Rhodoplanes and Hungatella. On the C membranes, Natronoflexus, Tissierella and Johnsonella were detected. These bacterial genera detected in different proportions on both membrane types are members of distinct and metabolically different bacteria providing insight into complex and dependent correlations inside specific microbial niche like biofilms created on d-PTFE membranes. Interestingly, the genus Natronoflexus was detected mainly on C membranes, suggesting a difference in the biofilm pH with likely more alkaline values at certain time point of biofilm formation. Genera Selenomonas, Parvimonas, Peptostreptococcus, Dialister, Fretibacterium, Shuttleworthia and Solobacterium displayed consistently higher levels in the Cytoplast™ samples, confirming higher bacterial genera abundance of relevance in the context of periodontal and peri-implant diseases and alveolar bone loss. Increased abundance of Peptostreptococcus, Selenomonas and Parvimonas in Cytoplast™ biofilms further implicates that C membranes has an enhanced potential for a dysbiotic shift in microbial communities, which may pose a clinical risk for tissue and bone health [28,29,30].
This differential colonization pattern points to a potential role of membrane-specific properties and specific microenvironment in shaping microbial community structure. Early colonization by dysbiotic taxa could affect wound stability, inflammatory processes and bone remodeling. Short-term dysbiosis may have long-term clinical implications despite membrane removal. The clinical implications of various d-PTFE membranes employed in guided bone regeneration merit further comprehensive research. Given that these membranes are typically removed after a four-week period, additional studies are essential to thoroughly assess bone regeneration outcomes and to monitor potential complications, including tissue infections and bone loss.

5. Conclusions

Microbial communities adherent on different membranes represent fluid and changing biofilm microenvironments consistent with a wide palette of microorganisms.
When compared, two distinct d-PTFE membranes differed in their temporal biofilm microbiome profiles after a four-week exposure and healing period during guided bone regeneration; the Cytoplast™ membrane represented a better surface for adhesion and bacterial accumulation compared to the Permamem® membrane, considering the higher overall 16s rRNA sequence read number. When analyzing the microbial profile of biofilms adherent on Cytoplast™ or Permamem® d-PTFE membranes, Permamem® membranes generate a biofilm enriched in health-associated bacterial genera and species like Strepococcus, Corynebacterium and Kingella. Cytoplast™ membranes showed reduced microbial diversity and enhanced quantity of pathobionts like Selenomonas and periodontal, peri-implant diseases and alveolar bone loss related bacterial genera, like Segatella, Fusobacterium and Parvimonas. Other disease-related bacterial genera like Peptostreptococcus, Mogibacterium, Dialister, Fretibacterium, Shuttleworthia and Solobacterium presented a similar trend of increased presence in Cytoplast™ membranes. When considering bacterial species which may lead into dysbiosis, Segatella maculosa and different Fusobacterium species were also more abundant in the Cytoplast™ group. Overall, our result showed that Cytoplast™ membranes generate a specific kind of biofilm, leading to reduction in health-related bacterial species and facilitating growth conditions for dysbiosis shift, pathobiont and pathogen species dominance. Further research and patient follow-ups are essential to thoroughly evaluate the clinical implications of different d-PTFE membranes used in guided bone regeneration.

Author Contributions

Conceptualization, B.M.V., B.F., I.R. and O.C.P.; methodology, B.M.V., B.F., M.B., D.G., I.R. and G.B.; software, I.R.; formal analysis, B.M.V., M.B. and I.R.; investigation, M.B., D.G., B.F., G.B. and O.C.P.; writing—original draft preparation, B.M.V., B.F. and I.R.; writing—review and editing, M.N., G.B., T.Š.V., D.V. and O.C.P.; supervision, O.C.P. and D.K.; project administration, B.M.V., B.F. and O.C.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Croatian Science Foundation, grant number IP-2020-02-7875 and the University of Rijeka, grant number UNIRI-biomed grant number 2170-137-08-24-19.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki. The Ethics Committee of the Faculty of Medicine of the University of Rijeka (class: 003-05/20-1/151; no. 2170/29-02/1-20-2; 19 December 2020) approved the study of human participants who were willing to provide informed consent. The study is registered as a randomized controlled trial at ClinicalTrials.gov (NCT06694844, 18 November 2024).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Vernon, J.J.; Raïf, E.M.; Aw, J.; Attenborough, E.; Jha, A.; Do, T. Dental implant surfaces and their interaction with the oral microbiome. Dent. Rev. 2022, 2, 100060. [Google Scholar] [CrossRef]
  2. Dieckow, S.; Szafrański, S.P.; Grischke, J.; Qu, T.; Doll-Nikutta, K.; Steglich, M.; Yang, I.; Häussler, S.; Stiesch, M. Structure and composition of early biofilms formed on dental implants are complex, diverse, subject-specific and dynamic. npj Biofilms Microbiomes 2024, 10, 155. [Google Scholar] [CrossRef]
  3. Choi, W.; Mangal, U.; Park, J.Y.; Kim, J.Y.; Jun, T.; Jung, J.W.; Choi, M.; Jung, S.; Lee, M.; Na, J.Y.; et al. Occlusive membranes for guided regeneration of inflamed tissue defects. Nat. Commun. 2023, 14, 7687. [Google Scholar] [CrossRef]
  4. Zhang, M.; Zhou, Z.; Yun, J.; Liu, R.; Li, J.; Chen, Y.; Cai, H.; Jiang, H.B.; Lee, E.-S.; Han, J.; et al. Effect of Different Membranes on Vertical Bone Regeneration: A Systematic Review and Network Meta-Analysis. BioMed Res. Int. 2022, 2022, 7742687. [Google Scholar] [CrossRef] [PubMed]
  5. Altiparmak, N.; Akdeniz, S.S.; Akcay, Y.E.; Bayram, B.; Araz, K. Experimental assessment of histological and biological properties of the induced membrane and the membrane formed around the d-PTFE membrane: A pilot study. J. Stomatol. Oral Maxillofac. Surg. 2020, 121, 140–145. [Google Scholar] [CrossRef]
  6. Dayube, U.R.C.; Asbi, T.; Formiga, M.; Groisman, E.; Bortoli, J.P.; Lima, F.G.; Mayer, Y.; Haim, D.; Meinster, I.; Gabay, E.; et al. Volumetric Evaluation of Alveolar Ridge Preservation Using Dense PTFE (d-PTFE) Membranes Intentionally Exposed to the Oral Cavity After Immediate Implant Placement—A Retrospective Study. Dent. J. 2025, 13, 58. [Google Scholar] [CrossRef]
  7. Kreve, S.; Reis, A.C.D. Bacterial adhesion to biomaterials: What regulates this attachment? A review. Jpn. Dent. Sci. Rev. 2021, 57, 85–96. [Google Scholar] [CrossRef]
  8. Franović, B.; Čandrlić, M.; Blašković, M.; Renko, I.; Milas, K.K.; Markova-Car, E.P.; Vitezić, B.M.; Gabrić, D.; Gobin, I.; Vranić, S.M.; et al. The Microbial Diversity and Biofilm Characteristics of d-PTFE Membranes Used for Socket Preservation: A Randomized Controlled Clinical Trial. J. Funct. Biomater. 2025, 16, 40. [Google Scholar] [CrossRef]
  9. Begić, G.; Didović, M.P.; Blagojević, S.L.; Badovinac, I.J.; Žigon, J.; Perčić, M.; Peloza, O.C.; Gobin, I. Adhesion of Oral Bacteria to Commercial d-PTFE Membranes: Polymer Microstructure Makes a Difference. Int. J. Mol. Sci. 2022, 23, 2983. [Google Scholar] [CrossRef] [PubMed]
  10. Hu, W.; Chen, S.; Zou, X.; Chen, Y.; Luo, J.; Zhong, P.; Ma, D. Oral microbiome, periodontal disease and systemic bone-related diseases in the era of homeostatic medicine. J. Adv. Res. 2024, 73, 443–458. [Google Scholar] [CrossRef]
  11. Cheng, X.; Zhou, X.; Liu, C.; Xu, X. Oral Osteomicrobiology: The Role of Oral Microbiota in Alveolar Bone Homeostasis. Front. Cell. Infect. Microbiol. 2021, 11, 751503. [Google Scholar] [CrossRef]
  12. Galindo-Moreno, P.; Gutierrez-Garrido, L.; Duarte, J.; Robles-Vera, I.; Martin-Morales, N.; O’VAlle, F.; Olaechea, A.; Carrillo-Galvez, A.B.; Padial-Molina, M. Evolution in the Peri-Implant Oral Microbiome and Their Relationship to Long-Term Marginal Bone Loss: A Randomized Clinical Study. Clin. Oral Implant. Res. 2025, 36, 802–820. [Google Scholar] [CrossRef]
  13. Talib, E.Q.; Taha, G.I.; Ali, D.M.; Al-Hindawi, S.H.; Al-Khayat, F.A.A.; Hasan, I.A. Microbial boundaries in peri-implantitis: A review of pathogen-related advances. Folia Medica 2024, 66, 763–769. [Google Scholar] [CrossRef] [PubMed]
  14. Hitch, T.C.A.; Bisdorf, K.; Afrizal, A.; Riedel, T.; Overmann, J.; Strowig, T.; Clavel, T. A taxonomic note on the genus Prevotella: Description of four novel genera and emended description of the genera Hallella and Xylanibacter. Syst. Appl. Microbiol. 2022, 45, 126354. [Google Scholar] [CrossRef] [PubMed]
  15. Kadirvelu, L.; Sivaramalingam, S.S.; Jothivel, D.; Chithiraiselvan, D.D.; Karaiyagowder Govindarajan, D.; Kandaswamy, K. A review on antimicrobial strategies in mitigating biofilm-associated infections on medical implants. Curr. Res. Microb. Sci. 2024, 6, 100231. [Google Scholar] [CrossRef]
  16. Caldara, M.; Belgiovine, C.; Secchi, E.; Rusconi, R. Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices. Clin. Microbiol. Rev. 2022, 35, e00221-20. [Google Scholar] [CrossRef] [PubMed]
  17. Bolyen, E.; Rideout, J.R.; Dillon, M.R.; Bokulich, N.A.; Abnet, C.C.; Al-Ghalith, G.A.; Alexander, H.; Alm, E.J.; Arumugam, M.; Asnicar, F.; et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 2019, 37, 852–857, Erratum in Nat. Biotechnol. 2019, 37, 1091. [Google Scholar] [CrossRef]
  18. Callahan, B.J.; McMurdie, P.J.; Rosen, M.J.; Han, A.W.; Johnson, A.J.A.; Holmes, S.P. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 2016, 13, 581–583. [Google Scholar] [CrossRef]
  19. Quast, C.; Pruesse, E.; Yilmaz, P.; Gerken, J.; Schweer, T.; Yarza, P.; Gerken, J.; Schweer, T.; Yarza, P.; Peplies, P.; et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 2012, 41, D590–D596. [Google Scholar] [CrossRef]
  20. Kim, B.R.; Shin, J.; Guevarra, R.B.; Lee, J.H.; Kim, D.W.; Seol, K.H.; Kim, H.B.; Isaacson, R.E. Deciphering Diversity Indices for a Better Understanding of Microbial Communities. J. Microbiol. Biotechnol. 2017, 27, 2089–2093. [Google Scholar] [CrossRef]
  21. Lu, Y.; Zhou, G.; Ewald, J.; Pang, Z.; Shiri, T.; Xia, J. MicrobiomeAnalyst 2.0: Comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res. 2023, 51, W310–W318. [Google Scholar] [CrossRef]
  22. Kers, J.G.; Saccenti, E. The Power of Microbiome Studies: Some Considerations on Which Alpha and Beta Metrics to Use and How to Report Results. Front. Microbiol. 2022, 12, 796025. [Google Scholar] [CrossRef] [PubMed]
  23. Gloor, G.B.; Macklaim, J.M.; Fernandes, A.D. Displaying Variation in Large Datasets: Plotting a Visual Summary of Effect Sizes. J. Comput. Graph. Stat. 2016, 25, 971–979. [Google Scholar] [CrossRef]
  24. Krishnan, K.; Chen, T.; Paster, B. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2016, 23, 276–286. [Google Scholar] [CrossRef] [PubMed]
  25. Socransky, S.S.; Haffajee, A.D.; Cugini, M.A.; Smith, C.; Kent, R.L. Microbial complexes in subgingival plaque. J. Clinic. Periodontol. 1998, 25, 134–144. [Google Scholar] [CrossRef]
  26. Kolenbrander, P.E.; Andersen, R.N.; Blehert, D.S.; Egland, P.G.; Foster, J.S.; Palmer, R.J. Communication among Oral Bacteria. Microbiol. Mol. Biol. Rev. 2002, 66, 486–505. [Google Scholar] [CrossRef]
  27. Aruni, A.W.; Mishra, A.; Dou, Y.; Chioma, O.; Hamilton, B.N.; Fletcher, H.M. Filifactor alocis—A new emerging periodontal pathogen. Microbes Infect. 2015, 17, 517–530. [Google Scholar] [CrossRef]
  28. Rams, T.E.; Feik, D.; Listgarten, M.A.; Slots, J. Peptostreptococcus micros in human periodontitis. Oral Microbiol. Immunol. 1992, 7, 1–6. [Google Scholar] [CrossRef]
  29. Colombo, A.P.V.; Boches, S.K.; Cotton, S.L.; Goodson, J.M.; Kent, R.; Haffajee, A.D.; Socransky, S.S.; Hasturk, H.; Van Dyke, T.E.; Dewhirst, F.; et al. Comparisons of Subgingival Microbial Profiles of Refractory Periodontitis, Severe Periodontitis, and Periodontal Health Using the Human Oral Microbe Identification Microarray. J. Periodontol. 2009, 80, 1421–1432. [Google Scholar] [CrossRef] [PubMed]
  30. Kumar, P.S.; Griffen, A.L.; Barton, J.A.; Paster, B.J.; Moeschberger, M.L.; Leys, E.J. New Bacterial Species Associated with Chronic Periodontitis. J. Dent. Res. 2003, 82, 338–344. [Google Scholar] [CrossRef]
  31. Griffen, A.L.; Beall, C.J.; Campbell, J.H.; Firestone, N.D.; Kumar, P.S.; Yang, Z.K.; Podar, M.; Leys, E.J. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2011, 6, 1176–1185. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Bacterial species detected at the phylum level in the Cytoplast™ and Permamem® group. * indicates p < 0.05.
Figure 1. Bacterial species detected at the phylum level in the Cytoplast™ and Permamem® group. * indicates p < 0.05.
Microorganisms 13 02478 g001
Figure 2. Heat tree at the level of species, (a) p < 0.05, (b) p < 0.01, (c) p < 0.001.
Figure 2. Heat tree at the level of species, (a) p < 0.05, (b) p < 0.01, (c) p < 0.001.
Microorganisms 13 02478 g002
Figure 3. Core microbiome bacteria on the level of (a) genus and (b) species.
Figure 3. Core microbiome bacteria on the level of (a) genus and (b) species.
Microorganisms 13 02478 g003
Figure 4. Rare and uncommon bacteria on the level of (a) genus and (b) species.
Figure 4. Rare and uncommon bacteria on the level of (a) genus and (b) species.
Microorganisms 13 02478 g004
Figure 5. Bacterial genera specific for either Permamem® or Cytoplast™ samples.
Figure 5. Bacterial genera specific for either Permamem® or Cytoplast™ samples.
Microorganisms 13 02478 g005
Figure 6. Dysbiosis and disease-related bacterial genera.
Figure 6. Dysbiosis and disease-related bacterial genera.
Microorganisms 13 02478 g006
Table 1. Differing bacterial species among Permamem® and Cytoplast™ groups detected at a significance threshold of p < 0.05 –0.01, p < 0.01–0.001 and p < 0.001. Blue stands for enhanced species presence in Cytoplast™ and red stands for greater species presence in Permamem® group).
Table 1. Differing bacterial species among Permamem® and Cytoplast™ groups detected at a significance threshold of p < 0.05 –0.01, p < 0.01–0.001 and p < 0.001. Blue stands for enhanced species presence in Cytoplast™ and red stands for greater species presence in Permamem® group).
p (<0.05–0.01)p (0.01–0.001)p < 0.001
Bacterial SpeciespBacterial SpeciespBacterial Speciesp
Acinetobacter johnsonii0.035Treponema maltophilum0.005Treponema socranskii0.00011
Acinetobacter oleivorans0.036Streptococus anginosus0.001Kingella bonacorsii1 × 10−5
Actinomyces bouchesdurhonensis0.020Streptococcus constellatus0.006Hoylesella saccharolytica0.00004
Actinomyces graevenitzii0.034Streptococcus porcinus0.007Haemophilus parainfluenzae0.0003
Actinomyces howellii0.011Slackia exigua0.001Fusobacterium vincentii0.0002
Actinomyces gerencseriae0.042Segatella salivae0.004Fusobacterium simiae0.0002
Anaerobacterium chartisolvens0.015Segatella oulorum0.002Fusobacterium animalis0.0003
Bradyrhizobium yuanmingense0.036Segatella albensis0.004Fusobacterium nucleatum0.0003
Cardiobacterium hominis0.025Rothia dentocariosa0.004Corynebacterium suicordis0.0007
Corynebacterium tuberculostearicum0.044Oribacterium asaccharolyticum0.003Corynebacterium pilbarense0.0006
Dialister invisus0.015Natronoflexus pectinivorans0.001Campylobacter gracilis0.0003
Eikenella halliae0.026Neisseria bacilliformis0.003Schaalia odontolytica0.000
Enterobacter hormaechei0.036Metamycoplasma salivarium0.001Mogibacterium. neglectum0.0007
Fusobacterium periodonticum0.019Micrococcus antarcticus0.001Peptostreptococcus stomatis0.0003
Corynebacterium matruchotii0.037Leptotrichia genomo sp. C10.004Segatella maculosa0.0005
Halothiobacillus neapolitanus0.018Klebsiella pneumoniae0.001
Leptotrichia shahii0.012Howardella ureilytica0.002
Atopobium rimae0.039Actinomyces massiliensis0.001
Leptotrichia wadei0.017Actinomyces odontolyticus0.005
Neisseria weaveri0.031Fusobacterium watanabei0.005
Parvimonas micra0.021Dialister pneumosintens0.001
Peptococcus niger0.018Curvibacter lanceolatus0.005
Prevotella micans0.034Conchiformibius kuhniae0.003
Pseudomonas lini0.039
Ruminiclostridium cellobioparum0.029
Segatella baroniae0.048
Selenomonas sputigena0.019
Treponema medium0.011
Table 2. Results of the ALDEx2 (analysis of differential abundance taking into account sampling variation) test (a) at the genus level and (b) at the species level.
Table 2. Results of the ALDEx2 (analysis of differential abundance taking into account sampling variation) test (a) at the genus level and (b) at the species level.
(a)
Bacterial genuswe.eBHDifference between P and C
Kingella0.000697.56497
Corynebacterium0.008204.77803
Fusobacterium0.02174−2.98425
Haemophilus0.007175.50947
Segatella0.01525−5.16926
(b)
Bacterial specieswe.eBHDifference between P and C
Fusobacterium vincentii0.00751−6.45941
Kingella bonacorsii0.001047.42369
Fusobacterium simiae0.00408−7.07080
Fusobacterium nucleatum0.02003−3.53571
Segatella maculosa0.00409−5.21526
Haemophilus parainfluenzae0.007725.74857
Fusobacterium nucleatum0.00852−7.15001
Positive value indicates enhanced abundance of bacterial genus and species (indicated in first table row) in Permamem® group, while negative value indicates enhanced abundance in Cytoplast™ group. we.eBH—short for Wilcoxon Effect—Benjamini–Hochberg p-value; P—Permamem® group; C—Cytoplast™ group.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Vitezić, B.M.; Franović, B.; Renko, I.; Kuiš, D.; Begić, G.; Blašković, M.; Gabrić, D.; Nikolić, M.; Vranić, T.Š.; Veljanovska, D.; et al. Microbiome Profiling of Biofilms Formed on d-PTFE Membranes Used in Guided Bone Regeneration. Microorganisms 2025, 13, 2478. https://doi.org/10.3390/microorganisms13112478

AMA Style

Vitezić BM, Franović B, Renko I, Kuiš D, Begić G, Blašković M, Gabrić D, Nikolić M, Vranić TŠ, Veljanovska D, et al. Microbiome Profiling of Biofilms Formed on d-PTFE Membranes Used in Guided Bone Regeneration. Microorganisms. 2025; 13(11):2478. https://doi.org/10.3390/microorganisms13112478

Chicago/Turabian Style

Vitezić, Bojana Mohar, Barbara Franović, Ira Renko, Davor Kuiš, Gabrijela Begić, Marko Blašković, Dragana Gabrić, Marina Nikolić, Tamara Šoić Vranić, Diana Veljanovska, and et al. 2025. "Microbiome Profiling of Biofilms Formed on d-PTFE Membranes Used in Guided Bone Regeneration" Microorganisms 13, no. 11: 2478. https://doi.org/10.3390/microorganisms13112478

APA Style

Vitezić, B. M., Franović, B., Renko, I., Kuiš, D., Begić, G., Blašković, M., Gabrić, D., Nikolić, M., Vranić, T. Š., Veljanovska, D., & Cvijanović Peloza, O. (2025). Microbiome Profiling of Biofilms Formed on d-PTFE Membranes Used in Guided Bone Regeneration. Microorganisms, 13(11), 2478. https://doi.org/10.3390/microorganisms13112478

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop